GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (MEX:BHC) » Definitions » Equity-to-Asset

Bausch Health (MEX:BHC) Equity-to-Asset : -0.04 (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bausch Health Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Bausch Health's Total Stockholders Equity for the quarter that ended in Sep. 2024 was MXN-23,116 Mil. Bausch Health's Total Assets for the quarter that ended in Sep. 2024 was MXN522,581 Mil. Therefore, Bausch Health's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was -0.04.

The historical rank and industry rank for Bausch Health's Equity-to-Asset or its related term are showing as below:

MEX:BHC' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.04   Med: 0.05   Max: 0.2
Current: -0.04

During the past 13 years, the highest Equity to Asset Ratio of Bausch Health was 0.20. The lowest was -0.04. And the median was 0.05.

MEX:BHC's Equity-to-Asset is ranked worse than
90.99% of 1043 companies
in the Drug Manufacturers industry
Industry Median: 0.6 vs MEX:BHC: -0.04

Bausch Health Equity-to-Asset Historical Data

The historical data trend for Bausch Health's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Equity-to-Asset Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.02 - -0.03 -0.04

Bausch Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.04 -0.04 -0.04 -0.04

Competitive Comparison of Bausch Health's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Bausch Health's Equity-to-Asset falls into.



Bausch Health Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Bausch Health's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=-17347.681/464245.683
=-0.04

Bausch Health's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=-23116.412/522580.562
=-0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bausch Health  (MEX:BHC) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Bausch Health Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Bausch Health's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.